RxDoctor Payments Data

Scott Evans, MD

Family Medicine · Mt Pleasant, SCNPI 1366464836

Payments from drug & device makers

$13,348in general payments, 2019–2025

Across 769 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$948
  • Novo Nordisk$816
  • Boehringer Ingelheim$687
  • plus $7K from 54 others

What the payments were for

  • Speaking & faculty fees$150%
  • Food & beverage$13,322100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer84$1,388
AbbVie(2 entities)85$1,225
AstraZeneca(2 entities)59$1,204
Amgen63$948
Novo Nordisk44$816
Boehringer Ingelheim41$687
Lilly USA, LLC34$628
Amarin Pharma, Inc.32$525
Merck37$502
GSK26$447
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$366
Eisai Inc.17$317
Exact Sciences16$302
Dexcom, Inc.8$291
Johnson & Johnson19$277
Biohaven Pharmaceutical Holding Company Ltd.12$256
Novartis16$243
Kowa Pharmaceuticals America, Inc.17$240
Astellas Pharma US Inc10$210
Takeda Pharmaceuticals U.S.A., Inc.10$202
Abbott9$197
Noven Therapeutics, LLC9$191
Esperion Therapeutics, Inc.11$180
Antares Pharma, Inc.7$148
Biohaven Pharmaceuticals, Inc.6$125
Daiichi Sankyo Inc.6$103
Sanofi-aventis U.S. LLC6$98
Bayer6$96
Genentech USA, Inc.6$96
Medicure Pharma Inc.3$84
Sumitomo Pharma America, Inc.3$75
Neuraxis, Inc.1$69
Corium, LLC3$66
Idorsia Pharmaceuticals US Inc4$57
Boston Scientific3$53
E.r. Squibb & Sons, L.L.C.3$50
Otsuka America Pharmaceutical, Inc.2$45
Shield Therapeutics Inc2$43
Phadia US Inc.2$42
Hikma Pharmaceuticals USA3$41
Abiomed1$37
Biogen2$33
Shire North American Group Inc2$27
Intuity Medical Inc1$26
Halozyme Inc1$24
Lundbeck LLC1$22
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$22
Paratek Pharmaceuticals, Inc.1$22
Xeris Pharmaceuticals, Inc.1$21
Ardelyx, Inc.1$20
Apria Healthcare LLC1$20
Renalytix AI, Inc.1$18
Regeneron Healthcare Solutions, Inc.1$17
Dynavax Technologies Corporation1$15
Collegium Pharmaceutical, Inc.1$15
Medtronic1$14
Arbor Pharmaceuticals, Inc.1$13
Currax Pharmaceuticals LLC1$13
Sanofi Pasteur Inc.1$13
Adlon Therapeutics L.p.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,348 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$379,719
Medicare patients
630
Services billed
8,776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide331$358,937
EliquisApixaban128$150,219
JardianceEmpagliflozin109$144,168
OzempicSemaglutide97$112,739
FarxigaDapagliflozin Propanediol61$71,988
JanuviaSitagliptin Phosphate43$50,948
XareltoRivaroxaban38$44,192
Xigduo XrDapaglifloz Propaned/Metformin33$33,699
Repatha SureclickEvolocumab40$30,841
LinzessLinaclotide20$28,494
MyrbetriqMirabegron30$24,250
LivaloPitavastatin Calcium29$23,193
JanumetSitagliptin Phos/Metformin Hcl14$22,746
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$18,663
Rosuvastatin Calcium811$12,071

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$628$358,937331 claims
PfizerEliquis, Lyrica$1,388$156,707139 claims
Boehringer IngelheimJardiance$687$144,168109 claims
Novo NordiskOzempic$816$112,73997 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,204$90,65176 claims
MerckJanuvia, Janumet$502$73,69357 claims
Johnson & JohnsonXarelto$277$44,19238 claims
AbbVieLinzess, Synthroid$1,225$34,21591 claims
Astellas Pharma US IncMyrbetriq$210$24,25030 claims
Kowa Pharmaceuticals America, Inc.Livalo$240$23,19329 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$202$5,24411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Mt Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →